From Medscape Psychiatry

Coverage from the

37th European College of Neuropsychopharmacology (ECNP) Congress

September 21 - 24, 2024; Milan, Italy

September 21 - 24, 2024 Milan, Italy

Conference News

Medscape Psychiatry© 

Popular News From ECNP 2023

  • Running vs Meds for Depression: Is There a Clear Winner? Running vs Meds for Depression: Is There a Clear Winner? A running therapy program rivals antidepressants in treatment of depression and anxiety, research suggests. Running showed greater physical health benefits while adherence is better with medication.
  • Intermittent Use of Benzodiazepines Is the Safest Option Intermittent Use of Benzodiazepines Is the Safest Option Intermittent benzodiazepine use significantly reduces the risk for falls, fractures, and mortality in older adults vs chronic use of these medications, results of a large-scale study show.
  • Esketamine Bests Quetiapine for Resistant Depression Esketamine Bests Quetiapine for Resistant Depression Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca) for treatment-resistant depression, results of a multicenter, head-to-head phase 3 trial show.

Previous Coverage